Search results - 1 result
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
s for moderate, and 4 DALY s for mild). Mean total lifetime costs reached €7.8 million per people with haemophilia, 94.3% being direct costs and 5.7% indirect costs. Clotting factors accounted for 82.5% ...